The consensus mark for outpatient medical and research portfolio rental income for the second quarter is pegged at $219.42 million, indicating growth from $218.88 million reported in the prior quarter and $215.81 million reported in the year-ago period. The Zacks Consensus Estimate for second-quarter resident fees and services is pegged at $815.27 million, suggesting an increase from $813.3 million reported in the prior quarter and $724.61 million in the year-ago period. The Zacks Consensus Estimate for sec ...

Over the past month, shares of this Zacks Rank #3 (Hold) company have risen 5.4% compared with the industry's upside of 1.8%. Competition from national and local healthcare operators may weigh on Ventas. The company's operators contend with peers for occupancy, which could limit its power to raise rents and drive profitability, as well as crack deals at attractive rates. Stocks to Consider The Zacks Consensus Estimate for Paramount Group's 2024 FFO per share has been raised marginally over the past month to ...

Washington, D.C. 20549 FORM 10-Q (Mark One) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Ventas, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 61-1055020 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 F ...

VENTAS® Earnings Presentation First Quarter 2024 Non-GAAP Financial Measures & Cautionary Statements Non-GAAP Financial Measures This presentation includes certain financial performance measures not defined by generally accepted accounting principles in the United States ("GAAP"), such as Nareit FFO, Normalized FFO, Net Operating Income ("NOI"), Same-Store Cash NOI, Same-Store Cash NOI Margin, Same-Store Cash NOI Growth and Net Debt to Further Adjusted EBITDA. Reconciliations of these non-GAAP financial mea ...

Ventas, Inc. (NYSE:VTR) Q1 2024 Earnings Conference Call May 2, 2024 10:00 AM ET Company Participants Bill Grant - SVP, IR Debra Cafaro - Chairman & CEO Justin Hutchens - EVP, Senior Housing & CIO Robert Probst - EVP & CFO Conference Call Participants James Kammert - Evercore Michael Carroll - RBC Capital Markets Michael Griffin - Citi Nicholas Joseph - Citi Omotayo Okusanya - Deutsche Bank Juan Sanabria - BMO Capital Markets Ronald Kamdem - Morgan Stanley Joshua Dennerlein - Bank of America Nicholas Yulico ...

CHICAGO – (BUSINESS WIRE) – Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") today reported results for the first quarter ended March 31, 2024. CEO Remarks "2024 is off to a strong start, led by continued organic growth in our advantaged senior housing operating portfolio ("SHOP"), as we execute against our strategy. Demand-driven accelerating occupancy in SHOP drove our performance in the quarter, as the unprecedented multiyear growth opportunity in senior housing continues to build," said Debra A. Caf ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number: 1-10989 Ventas, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 61-1055020 (State or Other Jurisdiction of Incorporation o ...

Ventas, Inc. (NYSE:VTR) Q4 2023 Earnings Conference Call February 15, 2024 1:00 PM ET Company Participants Bill Grant - SVP, IR Debra Cafaro - Chairman & CEO Justin Hutchens - EVP, Senior Housing & CIO Robert Probst - EVP & CFO Peter Bulgarelli - EVP, Outpatient Medical & Research Conference Call Participants Michael Mueller - JPMorgan Chase & Co. Nicholas Joseph - Citigroup Richard Anderson - Wedbush Securities Ronald Kamdem - Morgan Stanley Connor Siversky - Wells Fargo Securities Juan Sanabria - BMO Capi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM____________TO____________ Commission file number: 1-10989 Ventas, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 61-1055020 (State o ...

Ventas, Inc. (NYSE:VTR) Q3 2023 Earnings Conference Call November 3, 2023 10:00 AM ET Company Participants BJ Grant - SVP, IR Debra Cafaro - Chairman and CEO Justin Hutchens - CIO and EVP, Senior Housing Bob Probst - EVP and CFO Pete Bulgarelli - EVP and President and CEO, Lillibridge Healthcare Services, Inc. Conference Call Participants Austin Wurschmidt - KeyBanc Capital Markets Steve Sakwa - Evercore ISI Nick Joseph - Citi Juan Sanabria - BMO Capital Markets Mike Mueller - JPMorgan Ronald Kamdem - Morga ...